Susan Carino is a Director of Program Management with Mammoth Biosciences. She has over 30 years of industry experience in R&D across numerous therapeutic areas. She has led diverse cross-functional program teams engaged in complex product development of pharmaceuticals, biologics, medical devices, and in vitro diagnostics. She has managed projects in all life-cycle stages of product development ranging from research, development, clinical trials, regulatory submissions, product launches, post-approval regulatory commitments, and global expansion. Susan specializes in streamlining regulatory submission processes, agile project management, and leveraging project management best practices for successfully managing alliance partners.

Yoshiko Stowell, PhD, PMP is a Head of Regulatory Affairs at Neuron 23. She has over 19 years of diverse experience in Regulatory Affairs (Clinical and CMC), R&D, and Project Management. She has experience in all states of development from proof of concepts to global Phase III Clinical Studies and NDA/MAA approval for the treatment of CNS disorders, pain management, and rare diseases. Yoshiko is a RAPS-SF Chapter Chair. She is a Women in Bio (WIB) SF Chapter Chair of the Communication Committee and President of Regulatory Affairs Toastmasters (RAT) club. Yoshiko holds a BS in Chemistry from Tokyo University of Science, MS in Chemical Engineering from University of Oklahoma, and PhD in Pharmaceutical Science from University of the Pacific.